Silence Therapeutics Plc (SLN) compared with its closest peers (ALNY). Peer set by Pharmaceutical Products; 1 comparable drugmakers. First-party data.
Alnylam Pharmaceuticals shares Silence Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. (ALNY) | $33.20B | 62.0 |
| Sector P/E (Healthcare) | 19.4 |
| Industry P/E (Pharmaceutical Products) | 15.1 |
SLN overview · SLN earnings · SLN financials · SLN KPIs · SLN documents · SLN ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.